151 related articles for article (PubMed ID: 29069778)
21. B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study.
Xu PP; Zhong HJ; Huang YH; Gao XD; Zhao X; Shen Y; Cheng S; Huang JY; Chen SJ; Wang L; Zhao WL
EBioMedicine; 2017 Feb; 16():106-114. PubMed ID: 28153771
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX.
Liu H; Zhou G; Fu X; Cui H; Pu G; Xiao Y; Sun W; Dong X; Zhang L; Cao S; Li G; Wu X; Yang X
Oncotarget; 2017 Nov; 8(60):101899-101910. PubMed ID: 29254212
[TBL] [Abstract][Full Text] [Related]
23. TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway.
Li Y; Jia Z; Zhao H; Liu X; Luo J; Cui G; Kong X
J Oncol; 2021; 2021():5593720. PubMed ID: 33986803
[TBL] [Abstract][Full Text] [Related]
24. Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells.
Li Y; Huang S; Li Y; Zhang W; He K; Zhao M; Lin H; Li D; Zhang H; Zheng Z; Huang C
Tumour Biol; 2016 Oct; 37(10):14205-14215. PubMed ID: 27553025
[TBL] [Abstract][Full Text] [Related]
25. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
26. Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.
Ramachandiran S; Adon A; Guo X; Wang Y; Wang H; Chen Z; Kowalski J; Sunay UR; Young AN; Brown T; Mar JC; Du Y; Fu H; Mann KP; Natkunam Y; Boise LH; Saavedra HI; Lossos IS; Bernal-Mizrachi L
Int J Cancer; 2015 May; 136(10):2341-51. PubMed ID: 25359525
[TBL] [Abstract][Full Text] [Related]
27. Long Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.
Karstensen KT; Schein A; Petri A; Bøgsted M; Dybkær K; Uchida S; Kauppinen S
Noncoding RNA; 2020 Dec; 7(1):. PubMed ID: 33379241
[TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
Wanner K; Hipp S; Oelsner M; Ringshausen I; Bogner C; Peschel C; Decker T
Br J Haematol; 2006 Sep; 134(5):475-84. PubMed ID: 16856892
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA-LET is a positive prognostic factor and exhibits tumor-suppressive activity in gallbladder cancer.
Ma MZ; Kong X; Weng MZ; Zhang MD; Qin YY; Gong W; Zhang WJ; Quan ZW
Mol Carcinog; 2015 Nov; 54(11):1397-406. PubMed ID: 25213660
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA PANDA Positively Regulates Proliferation of Osteosarcoma Cells.
Kotake Y; Goto T; Naemura M; Inoue Y; Okamoto H; Tahara K
Anticancer Res; 2017 Jan; 37(1):81-85. PubMed ID: 28011477
[TBL] [Abstract][Full Text] [Related]
31. lncNBAT1/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells.
Li J; Chen Y; Guo X; Bai X; Xu X; Han T; Tan A; Liu N; Xia Y; Sun Q; Guo X; Chen J; Kang J
Mol Ther Nucleic Acids; 2022 Mar; 27():1064-1077. PubMed ID: 35228900
[TBL] [Abstract][Full Text] [Related]
32. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
[TBL] [Abstract][Full Text] [Related]
33. Long Non-coding RNA, PANDA, Contributes to the Stabilization of p53 Tumor Suppressor Protein.
Kotake Y; Kitagawa K; Ohhata T; Sakai S; Uchida C; Niida H; Naemura M; Kitagawa M
Anticancer Res; 2016 Apr; 36(4):1605-11. PubMed ID: 27069137
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives.
Huang X; Qian W; Ye X
Onco Targets Ther; 2020; 13():4295-4303. PubMed ID: 32547063
[TBL] [Abstract][Full Text] [Related]
35. MYC Protein-positive Diffuse Large B-Cell Lymphoma Features an Activated B-Cell Receptor Signal Pathway.
Wang WG; Jiang XN; Liu ZB; Zhou XY; Li XQ
Am J Surg Pathol; 2017 Apr; 41(4):541-549. PubMed ID: 28291124
[TBL] [Abstract][Full Text] [Related]
36. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
37. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers.
Ma C; Shi X; Zhu Q; Li Q; Liu Y; Yao Y; Song Y
Tumour Biol; 2016 Feb; 37(2):1437-44. PubMed ID: 26634743
[TBL] [Abstract][Full Text] [Related]
38. Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.
Dong L; Lv H; Li W; Song Z; Li L; Zhou S; Qiu L; Qian Z; Liu X; Feng L; Meng B; Fu K; Wang X; Pan-Hammarström Q; Wang P; Wang X; Zhang H
Oncotarget; 2016 May; 7(22):33350-62. PubMed ID: 27147575
[TBL] [Abstract][Full Text] [Related]
39. Identification of LINC00654-NINL Regulatory Axis in Diffuse Large B-Cell Lymphoma
Chen Y; Li C; Wang N; Wu Z; Zhang J; Yan J; Wei Y; Peng Q; Qi J
Front Oncol; 2022; 12():883301. PubMed ID: 35719990
[TBL] [Abstract][Full Text] [Related]
40. The biology of human lymphoid malignancies revealed by gene expression profiling.
Staudt LM; Dave S
Adv Immunol; 2005; 87():163-208. PubMed ID: 16102574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
